Frequency and prognosis of HER2-low status in Mexican patients with metastatic breast cancer

被引：1
|
作者：
Martinez-Cannon, Bertha Alejandra
Verduzco-Aguirre, Haydee Cristina
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P3-05-58
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-05-58
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Safety and Efficacy of Trastuzumab Deruxtecan for Metastatic HER2+and HER2-low Breast Cancer
    Qureshi, Zaheer
    Altaf, Faryal
    Jamil, Abdur
    Siddique, Rimsha
    Fatima, Eeshal
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (11): : 535 - 541
  • [22] Comprehensive genomic profiling results in patients with metastatic breast cancer due to germline BRCA1/2 status and their HER2-low status
    Tada, Hiroshi
    Miyashita, Minoru
    Harada-Shoji, Narumi
    Hamanaka, Yohei
    Sato, Miku
    Yanagaki, Mika
    Tsunokake, Satoko
    Motonari, Tokiwa
    Kon, Tomomi
    Yamazaki, Asumi
    Ishida, Takanori
    CANCER RESEARCH, 2024, 84 (09)
  • [23] Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer
    Geukens, Tatjana
    De Schepper, Maxim
    Richard, Francois
    Maetens, Marion
    Van Baelen, Karen
    Mahdami, Amena
    Nguyen, Ha-Linh
    Isnaldi, Edoardo
    Leduc, Sophia
    Pabba, Anirudh
    Zels, Gitte
    Mertens, Freya
    Borght, Sara Vander
    Smeets, Ann
    Nevelsteen, Ines
    Punie, Kevin
    Neven, Patrick
    Wildiers, Hans
    van den Bogaert, Wouter
    Floris, Giuseppe
    Desmedt, Christine
    EUROPEAN JOURNAL OF CANCER, 2023, 188 : 152 - 160
  • [24] Prognosis of patients with HER2-low breast cancer brain metastasis: A single-institution experience
    Xu, Hangcheng
    Wang, Yan
    Han, Yiqun
    Wu, Yun
    Sa, Qiang
    Wang, Jiayu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] Characterising HER2-low status in metastatic breast cancer: a real-world retrospective study of patients at a metropolitan cancer centre in Australia
    Li, Michelle
    Yeo, Belinda
    CANCER RESEARCH, 2024, 84 (09)
  • [26] Prevalence of HER2-low among Metastatic Breast Cancer Patients and Their Outcomes Compared to HER2 IHC 0
    Raghavendra, Akshara Singareeka
    Liu, Diane
    Mouabbi, Jason
    Tripathy, Debu
    CANCER RESEARCH, 2023, 83 (05)
  • [27] Pathological complete response and prognosis after neoadjuvant chemotherapy in patients with HER2-low breast cancer
    Qiao, Weiqiang
    Guo, Wanying
    Liu, Qipeng
    Guo, Xiao
    Deng, Miao
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2023, 64
  • [28] CHMP recommends Approval of ENHERTU® in the EU for Female Patients with HER2-low metastatic Breast Cancer
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (1-2)
  • [29] Characteristics and clinical outcomes of patients with HER2-low breast cancer
    Koh, S.
    Koi, Y.
    Tajiri, W.
    Kawasaki, J.
    Akiyoshi, S.
    Nakamura, Y.
    Koga, C.
    Tokunaga, E.
    BREAST, 2023, 68 : S32 - S32
  • [30] The effect of eribulin treatment for patients with HER2-low breast cancer
    Goto, Wataru
    Henmi, Saeko
    Nishikawa, Mariko
    Kouchi, Asuka
    Kouhashi, Rika
    Yabumoto, Akimichi
    Takada, Koji
    Asano, Yuka
    Tauchi, Yukie
    Ogisawa, Kana
    Morisaki, Tamami
    Kashiwagi, Shinichiro
    CANCER RESEARCH, 2024, 84 (09)
12345